Impact of attention-deficit/hyperactivity disorder on the patient and family: Results from a European survey

Child and Adolescent Psychiatry and Mental Health

Volumn 2, Issue , 2008, Pages

  Coghill, David ^a   Soutullo, Cesar ^b   d'Aubuisson, Carlos ^c   Preuss, Ulrich ^d   Lindback, Trygve ^c   Silverberg, Maria ^c   Buitelaar, Jan ^e  

^a Centre for Child Health   (United Kingdom)

^b UNIVERSITY CLINIC OF NAVARRA   (Spain)

^c Universitätsklinik für Kinder undJugendpsychiatrie Psychotherapie Bern ^*  (Sweden)

^d UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^e RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CENTRAL STIMULANT AGENT; LONG ACTING DRUG; SHORT ACTING DRUG;

ADOLESCENT; ADULT; ARTICLE; ATTENTION DEFICIT DISORDER; BEHAVIOR DISORDER; CHILD; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DISRUPTIVE BEHAVIOR; DRUG EFFICACY; EUROPE; FAMILY RELATION; FEMALE; HEALTH CARE PERSONNEL; HEALTH SURVEY; HUMAN; HUMAN RELATION; IMPULSIVENESS; MAJOR CLINICAL STUDY; MALE; ONLINE SYSTEM; PLAY; POPULATION RESEARCH; PRIORITY JOURNAL; QUESTIONNAIRE; SYMPTOM;

EID: 57149124886     PISSN: None     EISSN: 17532000     Source Type: Journal    
DOI: 10.1186/1753-2000-2-31     Document Type: Article

References (45)

1. American Academy of Pediatrics. Clinical practice guidelines: Diagnosis and evaluation of the child with attention-deficity/hyperactivity disorder. Pediatrics 2000, 105:1158-1170. 10.1542/peds.105.5.1158 10836893
2. Gaub M Carlson C: GendAr differences in ADHD: a meta-analysis and critical review. J Am Acad Child Adolesc Psychiatry 1997, 36:1036-1045. 10.1097/00004583-199708000-00011 9256583
3. Greene RW Biederman J Faraone SV Ouellette CA Penn C Griffin SM: Toward a new psychometric definition of social disability in children with attention-deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 1996, 35:571-578. 10.1097/00004583-199605000-00011 8935203
4. Stein MA Szumowski E Blondis TA Roizen NJ: Adaptive skills dysfunction in ADD and ADHD children. J Child Psychol Psychiatry 1995, 36:663-670. 7650089
5. Biederman J Faraone SV Spencer T Wilens T Norman D Lapey KA Mick E Lehman BK Doyle A: Patterns of psychiatric comorbidity, cognition, and psychosocial functioning in adults with attention deficit hyperactivity disorder. Am J Psychiatry 1993. 150:1792-1798. 8238632
6. Biederman J Faraone SV Taylor A Sienna M Williamson S Fine C: Diagnostic continuity between child and adolescent ADHD: Findings from a longitudinal clinical sample. J Am Acad Child Adolesc Psychiatry 1998, 37:305-313. 9519636
7. Wilens TE Biederman J Spencer TJ: Attention deficit/hyperactivity disorder across the lifespan. Annu Rev Med 2002, 53:113-131. 10.1146/ annurev.med.53.082901.103945 11818466
8. Biederman J Faraone S Milberger S Guite J Mick E Chen L Mennin D Marrs A Ouellette C Moore P Spencer T Norman D Wilens T Kraus I Perrin J: A prospective 4-year follow-up study of attention-deficit hyperactivity and related disorders. Arch Gen Psychiatry 1996, 53:437-446. 8624187
9. Barkley RA Fischer M Edelbrock CS Smallish L: The adolescent outcome of hyperactive children diagnosed by research criteria: I. An 8-year prospective follow-up study. J Am Acad Child Adolesc Psychiatry 1990, 29:546-557. 10.1097/00004583-199007000-00007 2387789
10. Biederman J Mick E Faraone SV: Normalized functioning in youths with persistent attention-deficit/hyperactivity disorder. J Pediatr 1998, 133:544-551. 10.1016/S0022-3476(98)70065-4 9787695
11. DiScala C Lescohier I Barthel M Li G: Injuries to children with attention deficit hyperactivity disorder. Pediatrics 1998, 102:1415-1421. 10.1542/peds.102.6.1415 9832578
12. Jensen PS Shervette RE 3rd Xenakis SN Bain MW: Psychosocial and medical histories of stimulant-treated children. J Am Acad Child Adolesc Psychiatry 1988, 27:798-801. 2904428
13. Anderson JC Williams S McGee R Silva PA: DSM-III disorders in preadolescent children. Prevalence in a large sample from the general population. Arch Gen Psychiatry 1987, 44:69-76. 2432848
14. Bird HR Gould MS Staghezza BM: Patterns of diagnostic comorbidity in a community sample of children aged 9 through 16 years. J Am Acad Child Adolesc Psychiatry 1993, 32:361-368. 10.1097/00004583-199303000-00018 8444766
15. Biederman J Newcorn J Sprich S: Comorbidity of attention deficit hyperactivity disorder with conduct, depressive, anxiety, and other disorders. Am J Psychiatry 1991, 148:564-577. 2018156
16. Biederman J Wilens TE Mick E Faraone SV Spencer T: Does attention-deficit hyperactivity disorder impact the developmental course of drug and alcohol abuse and dependence?. Biol Psychiatry 1998, 44:269-273. 10.1016/S0006-3223(97)00406-X 9715358
17. Pomerleau OF Downey KK Stelson FW Pomerleau CS: Cigarette smoking in adult patients diagnosed with attention deficit hyperactivity disorder. J Subst Abuse 1995, 7:373-378. 10.1016/0899-3289(95)90030-6 8749796
18. Milberger S Biederman J Faraone SV Chen L Jones J: ADHD is associated with early initiation of cigarette smoking in children and adolescents. J Am Acad Child Adolesc Psychiatry 1997, 36:37-44. 10.1097/ 00004583-199701000-00015 9000779
19. Brown R Pacinin J: Perceived family functioning, marital status and depression in parents of boys with attention deficit disorder. J Learn Disabil 1989, 22:581-587. 2809411
20. Noe L Hankin C: Health outcomes of childhood attention-deficit/ hyperactivity disorder (ADHD): Health care use and work status of caregivers. Value Health 2001, 4:142-143. 10.1046/ j.1524-4733.2001.40202-196.x
21. Pelham WE Foster EM Robb JA: The economic impact of attention-deficit/ hyperactivity disorder in children and adolescents. J Pediatr Psychol 2007. 32:711-727. 10.1093/jpepsy/jsm022 17556402
22. Hakkaart-van Roijen L Zwirs BW Bouwmans C Tan SS Schulpen TW Vlasveld L Buitelaar JK: Societal costs and quality of life of children suffering from attention deficient hyperactivity disorder (ADHD). Eur Child Adolesc Psychiatry 2007. 16:316-326. 10.1007/s00787-007-0603-6 17483870
23. Leibson CL Katusic SK Barbaresi WJ Ransom J O'Brien PC: Use and costs of medical care for children and adolescents with and without attention-deficit/hyperactivity disorder. Jama 2001, 285:60-66. 10.1001/ jama.285.1.60 11150110
24. Greenhill LL Halperin JM Abikoff H: Stimulant medications. J Am Acad Child Adolesc Psychiatry 1999, 38:503-512. 10.1097/ 00004583-199905000-00011 10230181
25. Spencer T Biederman J Wilens T Harding M O'Donnell D Griffin S: Pharmacotherapy of attention-deficit hyperactivity disorder across the life cycle. J Am Acad Child Adolesc Psychiatry 1996, 35:409-432. 8919704
26. Taylor E Dopfner M Sergeant J Asherson P Banaschewski T Buitelaar J Coghill D Danckaerts M Rothenberger A Sonuga-Barke E Steinhausen HC Zuddas A: European clinical guidelines for hyperkinetic disorder - first upgrade. Eur Child Adolesc Psychiatry 2004, 13(Suppl 1):17-30. 15322953
27. Pelham WE Gnagy EM Burrows-Maclean L Williams A Fabiano GA Morrisey SM Chronis AM Forehand GL Nguyen CA Hoffman MT Lock TM Fielbelkorn K Coles EK Panahon CJ Steiner RL Meichenbaum DL Onyango AN Morse GD: Once-a-day Concerta methylphenidate versus three-times-daily methylphenidate in laboratory and natural settings. Pediatrics 2001, 107:E105. 10.1542/ peds.107.6.e105 11389303
28. Swanson J Gupta S Lam A Shoulson I Lerner M Modi N Lindemulder E Wigal S: Development of a new once-a-day formulation of methylphenidate for the treatment of attention-deficit/hyperactivity disorder: proof-of-concept and proof-of-product studies. Arch Gen Psychiatry 2003, 60:204-211. 10.1001/archpsyc.60.2.204 12578439
29. Favreau A Deseille-Turlotte G Brault F Giraudeau B Krier C Barthez MA Castelnau P: [Benefit of the extended-release methylphenidate formulations: A comparative study in childhood]. Arch Pediatr 2006, 13:442-448. 10.1016/j.arcped.2006.02.004 16597499
30. Biederman J Quinn D Weiss M Markabi S Weidenman M Edson K Karlsson G Pohlmann H Wigal S: Efficacy and safety of Ritalin LA, a new, once daily, extended-release dosage form of methylphenidate, in children with attention deficit hyperactivity disorder. Paediatr Drugs 2003, 5:833-841. 10.2165/00148581-200305120-00006 14658924
31. Marcus SC Wan GJ Kemner JE Olfson M: Continuity of methylphenidate treatment for attention-deficit/hyperactivity disorder. Arch Pediatr Adolesc Med 2005. 159:572-578. 10.1001/archpedi.159.6.572 15939858
32. The MTA Cooperative Group. A 14-month randomised clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 1999. 56:1073-1086. 10.1001/archpsyc.56.12.1073 10591283
33. Wilens TE Faraone SV Biederman J Gunawardene S: Does stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature. Pediatrics 2003, 111:179-185. 10.1542/peds.111.1.179 12509574
34. Prasad S Steer C: Switching from neurostimulant therapy to atomoxetine in children and adolescents with attention-deficit hyperactivity disorder: Clinical approaches and review of current available evidence. Paediatr Drugs 2008, 10:39-47. 10.2165/00148581-200810010-00005 18162007
35. Bangs ME Hazell P Danckaerts M Hoare P Coghill DR Wehmeier PM Williams DW Moore RJ Levine L: Atomoxetine for the treatment of attention-deficit/ hyperactivity disorder and oppositional defiant disorder. Pediatrics 2008, 121:e314-320. 10.1542/peds.2006-1880 18245404
36. Bakken RJ Paczkowski M Kramer HP Axelson AA Williams DW Malcolm SK Sumner CR Kelsey DK: Effects of atomoxetine on attention-deficit/ hyperactivity disorder in clinical pediatric treatment settings: A naturalistic study. Curr Med Res Opin 2008, 24:449-460. 10.1185/ 030079908X253627 18179733
37. Perring C: MediTating children: the case of Ritalin. Bioethics 1997, 11:228-240. 10.1111/1467-8519.00061 11654776
38. Pelham WE Jr Wheeler T Chronis A: Empirically supported psychosocial treatments for attention deficit hyperactivity disorder. J Clin Child Psychol 1998. 27:190-205. 10.1207/s15374424jccp2702_6 9648036
39. Pelham WE Fabino GA Massetti GM: Evidence-based assessment of attention deficit hyperactivity disorder in children and adolescents. J Clin Child Adolesc Psychol 2005, 34(3):449-76. 10.1207/s15374424jccp3403_5 16026214
40. Evans SW Schultz BK Sadler JM: Psychosocial interventions used to treat children with ADHD: Safety and efficacy. J Psychosoc Nurs Ment Health Serv 2008, 46:49-57. 18777968
41. Knight LA Rooney M Chronis-Tuscano A: Psychosocial treatments for attention-deficit/hyperactivity disorder. Curr Psychiatry Rep 2008, 10:412-418. 10.1007/s11920-008-0066-6 18803915
42. Chronis AM Jones HA Raggi Vl: Evidence-based psychosocial treatments for children and adolescents with attention-deficit/hyperactivity disorder. Clin Psychol Rev 2006, 26:486-502. 10.1016/j.cpr.2006.01.002 16483703
43. Danforth JS Harvey E Ulaszek WR McKee TE: The outcomes of group parent training for families of children with attention-deficit hyperactivity disorder and defiant/aggressive behaviour. J Behav Ther Exp Psychiatry 2006, 37:188-205. 10.1016/j.jbtep.2005.05.009 16112077
44. Kutcher S Aman M Brooks SJ Buitelaar J van Daalen E Fegert J Findling RL Fisman S Greenhill LL Huss M Kusumakar V Pine D Taylor E Tyano S: International consensus statement on attention-deficit/hyperactivity disorder (ADHD) and disruptive behaviour disorders (DBDs): Clinical implications and treatment practice suggestions. Eur Neuropsychopharmacol 2004, 14:11-28. 10.1016/S0924-977X(03)00045-2 14659983
45. Wolraich ML Greenhill LL Pelham W Swanson J Wilens T Palumbo D Atkins M McBurnett K Bukstein O: August G Randomized, controlled trial of oros methylphenidate once a day in children with attention-deficit/ hyperactivity disorder. Pediatrics 2001, 108:883-892. 10.1542/ peds.108.4.883 11581440